A Prodrug of a Selective Inhibitor of Inducible Nitric Oxide Synthase is Neuroprotective in the Rat Model of Glaucoma

Abstract

Pharmacological neuroprotection with a selective inhibitor of inducible nitric oxide synthase may be useful for the treatment of glaucoma.